Literature DB >> 12045367

The quality of life of patients with hypertension.

J D Stein1, G C Brown, M M Brown, S Sharma, H Hollands, H D Stein.   

Abstract

The authors evaluated the self-reported quality of life in patients with systemic arterial hypertension and assessed whether clinicians and normotensive respondents from the general public appreciate the impact that hypertension has on health-related quality of life. A quality-of-life questionnaire was completed by 385 individuals: persons with hypertension (n=188), normotensive persons (n=148), and clinicians (n=49). A utility score, which represents one's self-perceived health-related quality of life, was generated for each group by using standardized time tradeoff questionnaires. Quality of life with hypertension was judged to be significantly higher according to affected individuals (mean utility score, 0.980), compared with normotensive persons (mean utility score, 0.948) and clinicians (mean utility score, 0.942), who were asked to assume that they had hypertension (p<0.0005). Clinicians and normotensive individuals tend to overemphasize the impact that hypertension has on quality of life, as compared to affected patients. The relatively low impact that hypertensive individuals indicate high blood pressure has on their quality of life may contribute to their lack of compliance with treatment regimens. Copyright 2002 Le Jacq Communications, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045367      PMCID: PMC8101809          DOI: 10.1111/j.1524-6175.2002.00970.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

1.  Unmet needs in hypertension: challenges and opportunities.

Authors:  J D Jackson; P Merat
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

2.  Utilities and quality-adjusted life years.

Authors:  G W Torrance; D Feeny
Journal:  Int J Technol Assess Health Care       Date:  1989       Impact factor: 2.188

Review 3.  Quality of life as an outcome measure.

Authors:  C J Bulpitt
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

4.  Health status and hypertension: a population-based study.

Authors:  W F Lawrence; D G Fryback; P A Martin; R Klein; B E Klein
Journal:  J Clin Epidemiol       Date:  1996-11       Impact factor: 6.437

5.  Methodology for measuring health-state preferences--II: Scaling methods.

Authors:  D G Froberg; R L Kane
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

Review 6.  Evidence-based medicine, utilities, and quality of life.

Authors:  M M Brown; G C Brown; S Sharma; S Garrett
Journal:  Curr Opin Ophthalmol       Date:  1999-06       Impact factor: 3.761

Review 7.  A clinician's guide to utility measurement.

Authors:  D A Redelmeier; A S Detsky
Journal:  Prim Care       Date:  1995-06       Impact factor: 2.907

8.  Quality of life associated with diabetes mellitus in an adult population.

Authors:  G C Brown; M M Brown; S Sharma; H Brown; M Gozum; P Denton
Journal:  J Diabetes Complications       Date:  2000 Jan-Feb       Impact factor: 2.852

9.  Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration.

Authors:  G C Brown; M M Brown; S Sharma
Journal:  Can J Ophthalmol       Date:  2000-04       Impact factor: 1.882

10.  Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis.

Authors:  P M Rothwell; Z McDowell; C K Wong; P J Dorman
Journal:  BMJ       Date:  1997-05-31
View more
  18 in total

Review 1.  Value-based medicine and ophthalmology: an appraisal of cost-utility analyses.

Authors:  Gary C Brown; Melissa M Brown; Sanjay Sharma; Heidi Brown; Lindsay Smithen; David B Leeser; George Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  2004

2.  The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration.

Authors:  Gary C Brown; Melissa M Brown; Heidi C Brown; Sylvia Kindermann; Sanjay Sharma
Journal:  Trans Am Ophthalmol Soc       Date:  2007

3.  Quality of life with macular degeneration: perceptions of patients, clinicians, and community members.

Authors:  J D Stein; M M Brown; G C Brown; H Hollands; S Sharma
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

4.  The burden of age-related macular degeneration: a value-based medicine analysis.

Authors:  Gary C Brown; Melissa M Brown; Sanjay Sharma; Joshua D Stein; Zachary Roth; Joseph Campanella; George R Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  2005

5.  Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity.

Authors:  Vasileios Fragoulakis; Rossana Roncato; Chiara Dalle Fratte; Fabrizio Ecca; Marina Bartsakoulia; Federico Innocenti; Giuseppe Toffoli; Erika Cecchin; George P Patrinos; Christina Mitropoulou
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

6.  Utility values among glaucoma patients: an impact on the quality of life.

Authors:  V Gupta; G Srinivasan; S S Mei; G Gazzard; R Sihota; K S Kapoor
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

7.  A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy.

Authors:  Aslam H Anis; Huiying Sun; Sonia Singh; John Woolcott; Bohdan Nosyk; Marc Brisson
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

8.  Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator.

Authors:  Kate C Young; J C Teeters; Curtis G Benesch; John D Bisognano; Karl A Illig
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-10       Impact factor: 3.738

9.  Effect of 12 Weeks of Yoga Therapy on Quality of Life and Indian Diabetes Risk Score in Normotensive Indian Young Adult Prediabetics and Diabetics: Randomized Control Trial.

Authors:  Gorantla Shravya Keerthi; Pravati Pal; Gopal Krushna Pal; Jaya Prakash Sahoo; Magadi Gopalakrishna Sridhar; Jayaraman Balachander
Journal:  J Clin Diagn Res       Date:  2017-09-01

10.  An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY).

Authors:  Setareh A Williams; Eric L Michelson; Valerie A Cain; Min Yang; Shawna D Nesbitt; Brent M Egan; Stevo Julius
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.